Jessica R Kirshner

5PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCellular immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 21, 2026
Optimally engineered HLA/peptide-specific CAR-T cells outperform TCR-T cells to eradicate solid tumors.

Corinne E Decker, Jacqueline Idun, Katja Mohrs

|Mar 26, 2025
CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivo.

Robert Salzler, David J DiLillo, Kei Saotome

|Jul 27, 2022
Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054.

Richard Tavaré, Makenzie Danton, Jason T Giurleo

|Jan 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.

Dimitris Skokos, Janelle C Waite, Lauric Haber

|Jun 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer.

Alison Crawford, Lauric Haber, Marcus P Kelly

Pageof 1